Valink Therapeutics

Emerging

Company Overview

Valink Therapeutics is a Houston, Texas-based biotechnology company founded in 2020 developing antibody-drug conjugates (ADCs) for solid tumors using proprietary ValiLinker technology for site-specific payload conjugation. The company raised $20.5M total funding including an $11.8M Pre-Series A in October 2025, with a pipeline including VLT-03 (Phase I for solid tumors) and VLT-01 (solid tumors with brain metastases).

Revenue
$20.5M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Valink Therapeutics is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Valink Therapeutics performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Valink Therapeutics

See exactly how Valink Therapeutics ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Valink Therapeutics stacks up against competitors with our detailed comparison tool.

Start Comparison